In HCC, leucine rich repeat containing G protein-coupled receptor 5 bound and blocked the nuclear translocation of programmed cell death protein 5, reducing the stability of TP53 and promoting the degradation of TP53, thus promoting EMT and the drug resistance of HCC cells to doxorubicin [48]. This evidence concerns the gene LGR5 and hepatocellular carcinoma.